Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02472171 · ClinicalTrials.gov registry record · NA
Suppression of Postprandial Monocyte Activation by Blueberries or Docosahexaenoic Acid in Humans
A NA study, sponsored by USDA, Western Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT02472171: Completed NA study, sponsored by USDA, Western Human Nutrition Research Center.
NCT02472171 is a NA study that has completed, run by USDA, Western Human Nutrition Research Center. The registered enrollment target is 62 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02472171, a NA study, has completed, sponsored by USDA, Western Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
The overall goal of the research study is to determine whether a high-fat meal causes postprandial (after meal) inflammation, and whether eating n-3 polyunsaturated fatty acids (PUFAs) or blueberries that are rich in anti-inflammatory polyphenols suppress the inflammation in healthy people.
Primary Outcome
Change in monocyte activation using monocyte activation assay in whole blood.
Interventions
- DIETARY_SUPPLEMENT High saturated fat meal, placebo powder and sunflower oil
- DIETARY_SUPPLEMENT High saturated fat meal, blueberry powder and sunflower oil
- DIETARY_SUPPLEMENT High saturated fat meal, placebo powder and DHA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-11 |
| Phase | NA |
What the finished NCT02472171 record still lists
NCT02472171 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which High saturated fat meal, placebo powder and sunflower oil is the first listed.
NCT02472171 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02472171 about?
NCT02472171 is a clinical study titled "Suppression of Postprandial Monocyte Activation by Blueberries or Docosahexaenoic Acid in Humans". The overall goal of the research study is to determine whether a high-fat meal causes postprandial (after meal) inflammation, and whether eating n-3 polyunsaturated fatty acids (PUFAs) or blueberries that are rich in anti-inflammatory polyphenols suppress the inflammation in healthy people.
What is the current status of trial NCT02472171?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2015-06. Estimated completion is 2017-11.
What interventions are being tested in trial NCT02472171?
The interventions under investigation include: High saturated fat meal, placebo powder and sunflower oil (DIETARY_SUPPLEMENT), High saturated fat meal, blueberry powder and sunflower oil (DIETARY_SUPPLEMENT), High saturated fat meal, placebo powder and DHA (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02472171?
This trial is sponsored by USDA, Western Human Nutrition Research Center, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02472171's enrollment target sits among peer trials
62 1157th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia